CLAG-Based Induction Therapy in Previously Untreated High Risk Acute Myeloid Leukemia Patients

Highlights • 20 previously untreated AML patients were treated with CLAG based induction therapy. • The CR rate was 65% after one cycle and 80% after two cycles of therapy. • The mean duration of response is 36.8 months and the median overall survival is 29.0 months. • Patients with de novo AML had...

Full description

Saved in:
Bibliographic Details
Published inLeukemia research Vol. 46; pp. 74 - 78
Main Authors Seiter, Karen M.D, Ahmed, Nasir, Shaikh, Azfar, Baskind, Paul, Liu, Delong
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.07.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Highlights • 20 previously untreated AML patients were treated with CLAG based induction therapy. • The CR rate was 65% after one cycle and 80% after two cycles of therapy. • The mean duration of response is 36.8 months and the median overall survival is 29.0 months. • Patients with de novo AML had a 90.9% response to induction therapy and a median overall survival of 38.5 months.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0145-2126
1873-5835
DOI:10.1016/j.leukres.2016.04.015